0QCO
Pharming Group N.V.
Save
–
Market cap
59.75x
Current P/E
–
Forward P/E
About
Pharming Group N. V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
Similar securities
Based on sector and market capitalization
Report issue